Type 1 Diabetes: Advances in Research and Management

Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, necessitating lifelong insulin therapy for glycemic control. Recent advances in type 1 diabetes research focus on elucidating the immunopathogenesis of the disease and developing immunomodulatory therapies aimed at halting or delaying beta cell destruction. Innovations in insulin delivery systems, such as closed-loop systems or beta cell replacement therapies, aim to improve glycemic control and enhance quality of life for individuals with type 1 diabetes. Patient-centered care models emphasize individualized management strategies tailored to lifestyle preferences and treatment goals, highlighting the importance of multidisciplinary diabetes care teams in optimizing outcomes for individuals with type 1 diabetes.

    Related Conference of Type 1 Diabetes: Advances in Research and Management

    September 09-10, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    September 09-10, 2024

    4th European Endocrinology and Diabetes Congress

    Paris, France
    September 09-10, 2024

    33rd International Diabetes and Healthcare Conference

    Paris, France
    September 25-26, 2024

    5th World Summit on Diabetes Expo

    Rome, Italy
    October 14-15, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands
    November 27-28, 2024

    14th World Congress on Endocrinology and Diabetes

    Aix-en-Provence, France
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    May 19-20, 2025

    6nd World Summit on Diabetes

    Rome, Italy

    Type 1 Diabetes: Advances in Research and Management Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in